Evidence map›Paper›PMID 39679390›Full record

ArticleBiomedical optics express2024

BreakNet: discontinuity-resilient multi-scale transformer segmentation of retinal layers.

Razieh Ganjee, Bingjie Wang, Lingyun Wang, Chengcheng Zhao, José-Alain Sahel, Shaohua Pi

Abstract read
In one paragraph

Article in Biomedical optics express, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Razieh GanjeeDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.ORCID https://orcid.org/0000-0003-1848-3832
Bingjie WangDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.ORCID https://orcid.org/0000-0001-5056-7476
Lingyun WangDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.ORCID https://orcid.org/0000-0002-9380-6032
Chengcheng ZhaoDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
José-Alain SahelDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Shaohua PiDepartment of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.ORCID https://orcid.org/0000-0002-7549-8929

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yuanyuan Chen · 1989 to 2026
$17.8M
NEI NIH HHS P30 EY008098
6 · The paper itself

Abstract

Visible light optical coherence tomography (vis-OCT) is gaining traction for retinal imaging due to its high resolution and functional capabilities. However, the significant absorption of hemoglobin in the visible light range leads to pronounced shadow artifacts from retinal blood vessels, posing challenges for accurate layer segmentation. In this study, we present BreakNet, a multi-scale Transformer-based segmentation model designed to address boundary discontinuities caused by these shadow artifacts. BreakNet utilizes hierarchical Transformer and convolutional blocks to extract multi-scale global and local feature maps, capturing essential contextual, textural, and edge characteristics. The model incorporates decoder blocks that expand pathways to enhance the extraction of fine details and semantic information, ensuring precise segmentation. Evaluated on rodent retinal images acquired with prototype vis-OCT, BreakNet demonstrated superior performance over state-of-the-art segmentation models, such as TCCT-BP and U-Net, even when faced with limited-quality ground truth data. Our findings indicate that BreakNet has the potential to significantly improve retinal quantification and analysis.

Identifiers

PMID39679390
PMCPMC11640562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.